• M. Kokott, J. Breitkreutz, R. Wiedey
  The interplay of poorly soluble drug substances released from amorphous solid dispersions.
  Int. J. Pharm. X  7: 100243 (2024)
   

• R. Chamberlain, J. Breitkreutz, B. Fischer
  Drug content determination of low-dosed hot-melt extruded filaments using Raman spectroscopy.
  Pharm. Dev. Technol. 29: 258-264 (2024)
   

• V. Lura, S. Klinken, J. Breitkreutz
  A systematic investigation of external lubrication of mini-tablets on a rotary tablet press with focus on tensile strength.
  Eur. J. Pharm. Biopharm. 198: 114236 (2024)
   

• J. Kutzsche, G. Guzman, A. Willuweit, O. Kletke, E. Wollert, I. Gering, D. Jürgens, J. Breitkreutz, H. Stark, A. Beck-Sickinger, N. Klöcker, P. Hidalgo, D. Willbold
  An orally available N-type calcium channel inhibitor for the treatment of neuropathic pain.
  Br. J. Pharmacol. 1-23 (2024)

• J. Thissen, M.D. Klaßen, P. Constantinidis, M.C. Hacker, J. Breitkreutz, T. Teutenberg, B. Fischer
  Online coupling of size exclusion chromatography to capillary enhanced Raman spectroscopy for the analysis of proteins and biopharmaceutical drug products.
  Anal. Chem. 95: 17868–17877 (2023)
   
• V. Lura, S. Klinken, J. Breitkreutz
  Challenges in the transfer and scale-up of mini-tableting: Case study with losartan potassium.
  Eur. J. Pharm. Biopharm. 192: 161-173 (2023)
   
• V. Klingmann, M. Hinder, T.H. Langenickel, F. Chen, Y. Khder, J. Breitkreutz, H.M. Bosse
  Acceptability of multiple coated mini-tablets in comparison to syrup in infants and toddlers: a randomised controlled study.
  Arch. Dis. Child. 108: 730-735 (2023)
   
• L.C. Lammerding, J. Breitkreutz
  Technical evaluation of precisely manufacturing customized microneedle array patches via inkjet drug printing.
  Int. J. Pharm. 642: 123173 (2023)
   
• S. Stegemann, V. Klingmann; S. Reidemeister, J. Breitkreutz
  Patient-centric drug product development acceptability across patient populations - Science and evidence.
  Eur. J. Pharm. Biopharm. 188: 1-5 (2023)
   
• L. Hoffmann, J. Breitkreutz, J. Quodbach
  Investigation of the degradation and in-situ amorphization of the chiral drug escitalopram oxalate during Fused Deposition Modeling (FDM) 3D printing.
  Eur. J. Pharm. Sci. 185: 106423 (2023)
   
• J. Niessen, A. López Mármol, R. Ismail, J.T. Schiele, K. Rau, A. Wahl, K. Sauer, O. Heinzerling, J. Breitkreutz, M. Koziolek
  Application of biorelevant in vitro assays for the assessment and optimization of ASD-based formulations for pediatric patients
  Eur. J. Pharm. Biopharm. 185: 13-27 (2023)
   
• M. Kokott, S. Klinken, J. Breitkreutz, R. Wiedey
  Downstream processing of amorphous solid dispersions into orodispersible tablets
  Int. J. Pharm. 631: 122493 (2023)
   
• M. Fligge, I. Letofsky-Papst, M. Bäumers, A. Zimmer, J. Breitkreutz
  Personalized dermal patches – inkjet printing of nanosuspensions for individualized treatment of skin diseases
  Int. J. Pharm. 630: 122382 (2023)

• L. Hoffmann, J. Breitkreutz, J. Quodbach
  Fused Deposition Modeling (FDM) 3D printing of the thermos-sensitive peptidomimetic drug enalapril maleate
  Pharmaceutics 14: 2411 (2022)
   
• J. Kuck, J. Breitkreutz
  Impact of lubrication on key properties of orodispersible minitablets in comparison to conventionally sized orodispersible tablets
  Eur. J. Pharm. Biopharm. 180: 71-80 (2022)
   
• M. Hermeling, C. Nüboldt, R. Heumann, W. Hoheisel, J. Breitkreutz
  Nano-Dry-Melting: A novel technology for manufacturing of pharmaceutical amorphous solid dispersions
  Pharmaceutics 14: 2145 (2022)
   
• L. Hoffmann, J. Breitkreutz, J. Quodbach
  Hot-melt extrusion of the thermo-sensitive peptidomimetic drug enalapril maleate
  Pharmaceutics 14: 2091 (2022)
   
• B. Sarker, M. Fligge, T. Knaab, J. Breitkreutz
  Implementation of a new electronic liquid dispensing system for individualized compounding of hard capsules
  Pharmaceutics, 14: 1580 (2022)
   
• J. Rahman-Yildir, R. Wiedey, J. Breitkreutz
  Comparative dissolution studies of 3D-printed inserts in a novel biopharmaceutical bladder model
  Int. J. Pharm. 624: 121984 (2022)
   
• J. Rahman-Yildir, B. Fischer, J. Breitkreutz
  Development and optimization of sustained-release drug-loaded intravesical inserts via semi-solid micro-extrusion 3D printing for bladder targeting
  Int. J. Pharm. 622: 121849 (2022)
   
• S. Läer, W. Cawello, B.B. Burckhardt, L. Ablonczy, M. Bajcetic, J.M.P.J. Breur,
  M. Dalinghaus, C. Male, S.N. de Wildt, J. Breitkreutz, M. Faisal, A. Keatley-Clarke,
  I. Klingmann, F.B. Lagler
  Enalapril and enalaprilat pharmacokinetics in children with heart failure due to dilated cardiomyopathy and congestive heart failure after administration of an orodispersible enalapril minitablet (LENA-studies)
  Pharmaceutics 14: 1163 (2022)
   
• A. Lura, J. Breitkreutz
  Development and production of mini-tablets: Impact of the tableting tooling systems
  J. Drug Deliv. Sci. Technol. 72: 103357 (2022)
   
• H. Windolf, R. Chamberlain, J. Breitkreutz, J. Quodbach
  3D printed mini-floating-polypill for Parkinson’s disease: Combination of levodopa, benserazide, and pramipexole in various dosing for personalized therapy
  Pharmaceutics 14: 931 (2022)
   
• J. Quodbach, M. Bogdahn, J. Breitkreutz, R. Chamberlain, K. Eggenreich, A.G. Elia,
  N. Gottschalk, G. Gunkel-Grabole, L. Hoffmann, D. Kapote, T. Kipping, S. Klinken,
  F. Loose, T. Marquetant, H. Windolf, S. Geißler, T. Spitz
  Quality of FDM 3D printed medicines for pediatrics – Considerations for formulation development, filament extrusion, printing process and printer design
  Therapeutic Innovation & Regulatory Science 56: 910-928 (2022)
   
• R. Chamberlain, H. Windolf, B.B. Burckhardt, J. Breitkreutz, B. Fischer
  Embedding a sensitive liquid-core waiveguide UV detector coupled to HPLC for analysis of low-dosed pramipexole during drug dissolution
  Pharmaceutics 14: 639 (2022)
   
• V. Elezaj, A. Lura, L. Canha, J. Breitkreutz
  Pharmaceutical development of film-coated mini-tablets with Losartan Potassium for Epidermolysis Bullosa
  Pharmaceutics 14: 570 (2022)
   
• A. Göbel, J. Breitkreutz
  Concept of orodispersible or mucoadhesive “Tandem films” and their pharmaceutical realization
  Pharmaceutics 14: 264 (2022)
   
• R. Chamberlain, H. Windolf, J. Quodbach, S. Geissler, J. Breitkreutz
  Precise micro-dosing of pramiprexole filaments produced via hot-melt extrusion applying various feeding methods
  Pharmaceutics 14: 216 (2022)
   
• M. Kern, T. Riedel, J. Breitkreutz
  Investigating key properties of model excipients and binary powder blends using ultrasonic in-die measurements on a compaction simulator
  Int. J. Pharm. 613: 121381 (2022)
   
• R. Chamberlain, H. Windolf, J. Breitkreutz
  Innovative und etablierte Arzneizubereitungen für die Therapie des idiopathischen Parkinson-Syndroms
  Pharmakon 10: 216-226 (2022)

• R. Wiedey, M. Kokott, J. Breitkreutz
  Orodispersible tablets for pediatric drug delivery: current challenges and
  recent advances
  Exp. Opin. Drug Deliv. 18: 1873-1890 (2021)
   

• M. Müller, F. Platten, M. Dulle, B. Fischer, W. Hoheisel, P. Serno, S. Egelhaaf, J. Breitkreutz
  Precipitation from amorphous solid dispersions within biorelevant dissolution testing: The polymorphism of regorafenib
  Int. J. Pharm. 603: 120716 (2021)
   

• A. Lura, V. Elezaj, M. Kokott, B. Fischer, J. Breitkreutz
  Transfer and scale-up of the manufacturing of orodispersible mini-tablets from a compaction simulator to an industrial rotary tablet press
  Int. J. Pharm. 602: 120636 (2021)
   

• J.F. Alopaeus, A. Göbel, J. Breitkreutz, S.-A. Sande, I. Tho
  Investigation of hydroxypropyl-β-cyclodextrin inclusion complexation of two poorly soluble model drugs and taste-sensation - Effect of electrolytes, freeze-drying and incorporation into oral film formulations
  J. Drug Deliv. Sci. Techn. 61: 102245 (2021)
   

• O. Kiefer, B. Fischer, J. Breitkreutz
  Fundamental investigations into metoprolol tartrate deposition on orodispersible films by inkjet printing for individualized drug dosing
  Pharmaceutics 13: 247 (2021)
   

• M. Inoue, O. Kiefer, B. Fischer, J. Breitkreutz
  Raman monitoring of semi-continuously manufactured orodispersible films for individualized dosing
  J. Drug Deliv. Sci. Techn. 61: 102224 (2021)
   

• D. Kottke, B.B. Burckhardt, J. Breitkreutz, B. Fischer
  Enhanced sensitivity by a validated HPLC-coupled liquid-core waveguide fluorescence detector - A promising alternative between conventional fluorescence and mass spectrometric detection
  Talanta 226: 122145 (2021)
   

2020

• A. Lura, G. Tardy, P. Kleinebudde, J. Breitkreutz
  Tabletting of mini-tablets in comparison with conventionally sized tablets: Tabletting properties and tablet shapes
  Int. J. Pharm. X 2:100061 (2020)
   
• I. El Aita, J. Rahman, J. Breitkreutz, J. Quodbach
  3D-Printing with precise layer-wise dose adjustments for paediatric use via pressure-assisted microsyringe printing
  Eur. J. Pharm. Biopharm. 157: 59-65 (2020)
   
• D. Kottke, A. Lura, D.J. Lunter, J. Breitkreutz
  Manufacturing and characterisation of a novel composite dosage form for buccal drug administration
  Int. J. Pharm. 589: 119839 (2020)
   
• O. Kiefer, J. Breitkreutz
  Comparative investigations on key factors and print head designs for pharmaceutical inkjet printing
  Int. J. Pharm. 586: 119561 (2020)
   
• V. Klingmann, C.E. Pohly, T. Meissner, E. Mayatepek, A. Möltner, K. Flunkert, J. Breitkreutz, H.M. Bosse
  Acceptability of an orodispersible film compared to syrup in neonates and infants:  A randomized clinical trial
  Eur. J. Pharm. Biopharm. 151: 239-245 (2020)
   
• D. Kottke, H. Majid, J. Breitkreutz, B.B. Burckhardt
  Development and evaluation of mucoadhesive buccal dosage forms of  lidocaine hydrochloride by ex-vivo permeation studies
  Int. J. Pharm. 581: 119293 (2020)
   
• M. Ali, J. Tins, B.B. Burckhardt on behalf of LENA consortium
  Correction to: Fit-for-purpose quality control system in continuous bioanalysis during long-term pediatric studies
  AAPS J. 22: 37 (2020)
   
• I. El Aita, J. Breitkreutz, J. Quodbach
  Investigation of semi-solid formulations for 3D printing of drugs after prolonged storage to mimic real-life applications
  Eur. J. Pharm. Sci. 146: 105266 (2020)
   
• J.C. Visser, L. Wibier, O. Kiefer, M. Orlu, J. Breitkreutz, H.J. Woerdenbag, K. Taxis
  A paediatrics utilization study in the Netherlands to identify active pharmaceuticals ingredients suitable for inkjet printing on orodispersible films
  Pharmaceutics 12: 164 (2020)
   
• Van Hecken, B.B. Burckhardt, F. Khalil, J. de Hoon, I. Klingmann, M. Herbots, S. Laeer,  F.B. Lagler, J. Breitkreutz
  Relative bioavailability of enalapril administered as orodispersible minitablets in healthy adults
  Clin. Pharmacol. Drug Devel. 9: 203-213 (2020)
   

---

2019

• Lura, O. Luhn, J. Suarez Gonzales, J. Breitkreutz
  New orodispersible mini-tablets for paediatric use – A comparison of isomalt with a mannitol based co-processed excipient
  Int. J. Pharm. 572: 118804 (2019)
   
• Y. Tian, M. Orlu, H.J. Woerdenbag, M. Scarpa, O. Kiefer, D. Kottke, E. Sjöholm, H. Öblom, N. Sandler, W.L.J. Hinrichs, H.W. Frijlink, J. Breitkreutz, J.C. Visser
  Oromucosal films: from patient centricity to production by printing techniques
  Exp. Opin. Drug Deliv. 16: 981-993 (2019)
   
• M. Faisal, W. Cawello, B.B. Burckhardt, J. de Hoon, S. Laer, A. van Hecken, M. Herbort, J. Breitkreutz, W. Wiedey, I. Klingmann, L. Spatenkova, F. Lagler, A. Moder, F. Khalil
  Simultaneous semi-mechanistic population pharmacokinetic modeling analysis of enalapril and enalaprilat serum and urine concentrations from child appropriate orodispersible minitablets
  Frontiers in Paediatrics 7: 281 (2019)
   
• M. Faisal, W. Cawello, B.B. Burckhardt, S. Laer, J. de Hoon, A. van Hecken, M. Herbort, J. Breitkreutz, W. Wiedey, I. Klingmann, L. Spatenkova, F. Lagler, A. Moder, F. Khalil
  Model-dependent pharmacokinetic analysis of enalapril administered to healthy adult volunteers using orodispersible minitablets for use in pediatrics
  Drug Design, Development and Therapy 13: 481-490 (2019)
   
• M. Bajcetic, S.N. de Wildt, M. Dalinghaus, J. Breitkreutz, I. Klingmann, F.B. Lagler, A. Keatley-Clarke, J.M.P.J. Breur, C. Male, I. Jovanovic, A. Szatmári, L. Ablonczy, B.B. Burckhardt, W. Cawello, K. Kleine, E. Obercanin, L. Spatenkova, V. Swoboda, M. van der Meulen, P. Wagner, J. Walsh, S. Läer
  Orodispersible minitablets of enalapril for use in children with heart failure (LENA): Rationale and protocol for a multicentre pharmacokinetic bridging study and follow-up safety study,
  Contemporary Clinical Trials Communication 15: 100393 (2019)
   
• S. Niese, J. Breitkreutz, J. Quodbach                                                                     
  Development of a dosing device for individualized dosing of orodispersible warfarin films
  Int. J. Pharm. 561: 314-323 (2019)
   
• I. Speer, M. Preis, J. Breitkreutz
  Dissolution testing of oral film preparations: experimental comparison of compendial and non-compendial methods
  Int. J. Pharm. 561: 124-134 (2019)
   
• I. Speer, M. Preis, J. Breitkreutz
  Novel dissolution method for oral film preparations with modified release properties
  AAPS Pharm Sci. Tech. 20(1): 7 (2019)
   
• J. Peters, W. Taute, C. Döscher, M. Höft, R. Knöchel, J. Breitkreutz
  Moisture monitoring in fluid-bed granulation by multi-resonance microwave sensor: Applicability on crystal-water containing Donepezil granules
  AAPS Pharm Sci. Tech. 20(1): 6 (2019)
   
• I. ElAita, J. Quodbach, J. Breitkreutz
  On-demand manufacturing of immediate release levetiracetam tablets using pressure-assisted microsyringe printing
  Eur. J. Pharm. Biopharm. 134: 29-36 (2019)
   
• I. Speer, V. Lenhart, M. Preis, J. Breitkreutz
  Prolonged drug release from orodispersible films by incorporation of diclofenac-loaded micropellets Int. J. Pharm. 554: 149-160 (2019)
   

---

2018

• Y. Thabet, V. Klingmann, J. Breitkreutz
  Drug formulations: Standards and novel strategies for drug administration in pediatrics
  J. Clin. Pharmacol. 58: S26-S35 (2018)
   
• V. Klingmann, H. Linderskamp, T. Meissner, E. Mayatepek, A. Moeltner, J. Breitkreutz, H.M. Bosse
  Acceptability of multiple uncoated mini-tablets in infants and toddlers: a randomized controlled trial
  J. Pediatr. 201: 202-207 (2018)
   
• I. Speer, D. Steiner, Y. Thabet, J. Breitkreutz, A. Kwade
  Comparative study on disintegration methods for oral film preparations
  Eur. J. Pharm. Biopharm. 132: 50-61 (2018)
   
• Y. Thabet, R. Sibanc, J. Breitkreutz
  Printing pharmaceuticals by inkjet technology: Proof of concept for stand-alone and continuous in-line printing on orodispersible films
  J. Manuf. Process. 35: 205-2015 (2018)
   
• F.P. Fernandes, A.C. Fortes, S.G. Fonseca, J. Breitkreutz, H.G. Ferraz
  Manufacture and characterization of mucoadhesive buccal films based on pectin and gellan gum containing triamcinolone acetonide
  Int. J. Polym. Sci., Article ID 2403802 (2018)
   
• I. Speer, M. Preis, J. Breitkreutz
  Prolonged drug release properties for orodispersible films by combining hot-melt extrusion and solvent casting methods
  Eur. J. Pharm. Biopharm. 129: 66-73 (2018)
   
• Y. Thabet, D. Lunter, J. Breitkreutz
  Continuous ink-jet printing of enalapril maleate onto orodispersible film formulations
  Int. J. Pharm. 546: 180-187 (2018)
   
• Y. Thabet, D. Lunter, J. Breitkreutz
  Continuous manufacturing and analytical characterization of fixed-dose, multilayer orodispersible films
  Eur. J. Pharm. Sci. 117: 236–244 (2018)
   
• J. Peters, W. Taute, C. Döscher, R. Meier, M. Höft, R. Knöchel, J. Breitkreutz
  From laboratory- to pilot-scale: moisture monitoring in fluidized bed granulation by a novel microwave sensor using multivariate calibration approaches
  Drug Dev. Ind. Pharm. 44: 961-968 (2018)
   
• Y. Thabet, J. Walsh, J. Breitkreutz
  Flexible and precise dosing of enalapril maleate for all paediatric age groups utilizing orodispersible minitablets
  Int. J. Pharm. 541: 136-142 (2018)
   
• Y. Thabet, M. Slavkova, J. Breitkreutz
  10 years EU regulation of paediatric medicines – Impact on cardiovascular drug formulations
  Exp. Opin. Drug Deliv. 15: 261-270 (2018)
   
• G.F. Petrovick, J. Breitkreutz
  Spheronization of solid lipid extrudates: Elucidation of spheroid formation mechanism
  Eur. J. Pharm. Biopharm. 125: 148-158 (2018)
   
• J. Peters, A. Teske, W. Taute, C. Döscher, M. Höft, R. Knöchel, J. Breitkreutz
  Real-time process monitoring in a semi-continuous fluid-bed dryer – microwave resonance technology versus near-infrared spectroscopy
  Int. J. Pharm. 537: 193-201 (2018)
   
• G.F. Petrovick, P. Kleinebudde, J. Breitkreutz
  Orodispersible tablets containing taste-masked solid lipid pellets with metformin hydrochloride: Influence of process parameters on tablet properties
  Eur. J. Pharm. Biopharm. 122: 137-145 (2018)
   
• Y. Thabet, J. Breitkreutz
  Orodispersible films: Product transfer from lab-scale to continuous manufacturing
  Int. J. Pharm. 535: 285-292 (2018)
   

---

 

2017

• M. Münster, C. Schoch, C. Schmidt, J. Breitkreutz
  Multiparticulate system combining taste masking and immediate release properties for the aversive compound praziquantel
  Eur. J. Pharm. Sci. 109: 446-454 (2017)
   
• S. Lindert, J. Breitkreutz
  Oromucosal multilayer films for tailor-made, controlled drug delivery
  Expert Opin. Drug Deliv. 14: 1265-1279 (2017)
   
• M. Münster, A.H.A. Mohamed-Ahmed, L.I. Immohr, C. Schoch, C. Schmidt, C. Tuleu, J. Breitkreutz
  Comparative in vitro and in vivo taste assessment of liquid praziquantel formulations
  Int. J. Pharm. 529: 310-318 (2017)
   
• J. Peters, K. Bartscher, C. Döscher, W. Taute, M. Höft, R. Knöchel, J. Breitkreutz
  In-line moisture monitoring in fluidized bed granulation using a novel multi-resonance microwave sensor
  Talanta 170: 369-376 (2017)
   
• J. Peters, W. Taute, K. Bartscher, C. Döscher, M. Höft, R. Knöchel, J. Breitkreutz
  Design, development and method validation of a novel multi-resonance microwave sensor for moisture measurement
  Anal. Chim. Acta 961: 119-127 (2017)
   
• M. Preis, J. Breitkreutz
  Pediatric Drug Development and Dosage Form Design
  AAPS PharmSciTech 18: 239-240 (2017)
   

---

 

2016

• V. Klingmann, Y. Thabet, J. Breitkreutz
  Arzneiformen für Kinder
  Pharmakon 4: 134-140 (2016)
   
• L.H.E. Leithold, N. Jiang, J. Post, N. Niemietz, E. Schartmann, T. Ziehm, J. Kutzsche, N. J. Shah; J. Breitkreutz; K.J. Langen, A. Willuweit, D. Willbold
  Pharmacokinetic properties of tandem D-peptides designed for treatment of Alzheimer's disease
  Eur. J. Pharm. Sci. 89: 31-38 (2016)
   
• G.F. Petrovick, J. Breitkreutz, M. Pein
  Taste-masking properties of solid lipid based micropellets obtained by cold extrusion-spheronization
  Int. J. Pharm. 506: 361-370 (2016)
   
• R. Krampe, J.C. Visser, H.W. Frijlink, J. Breitkreutz, H.J. Woerdenbag, M. Preis
  Oromucosal film preparations: points to consider for patient centricity and manufacturing processes
  Expert Opin. Drug Deliv. 13:493-506 (2016)
   
• L.H.E. Leithold, N. Jiang, J. Post, T. Ziehm, E. Schartmann, J. Kutzsche, N.J. Shah, J. Breitkreutz, K.-J. Langen, A. Willuweit, D. Willbold
  Pharmacokinetic properties of a novel D-peptide developed to be therapeutically active against toxic ß-amyloid oligomers
  Pharm. Res. 33: 328-336 (2016)
   
• A. de Beaumais Tiphaine, L.L. Hjalgrim, J. Nersting, J. Breitkreutz, B. Nelken, M. Schrappe, M. Stanulla, C. Thomas, Y. Bertrand, G. Leverger, A. Baruchel, K. Schmiegelow, E. Jacqz-Aigrain
  Evaluation of a pediatric liquid formulation to improve 6-mercaptopurine therapy in children
  Eur. J. Pharm. Sci. 83: 1-7 (2016)
   
• E.J. Laukamp, K. Knop, M. Thommes, J. Breitkreutz
  Micropellet-loaded rods with dose-independent sustained release properties for individual dosing via the Solid Dosage Pen
  Int. J. Pharm., 499: 271-279 (2016)
   
• R. Krampe, D. Sieber, M. Pein, J. Breitkreutz
  A new biorelevant dissolution method for orodispersible films
  Eur. J. Pharm. Biopharm. 98: 20-25 (2016)
   

---

2015

• V. Klingmann, A. Seitz, T. Meissner, J. Breitkreutz, A. Moeltner, H.M. Bosse
  Acceptability of uncoated minitablets in neonates – a randomized controlled trial
  J. Pediatr. 167: 893-896 (2015)
   
• M. Preis, J. Breitkreutz, N. Sandler
  Perspective: Concepts of printing technologies for oral film formulations
  Int. J. Pharm. 494: 578-84 (2015)
   
• N. Jiang, L.H.E. Leithold, J. Post, T. Ziehm, J. Mauler, K.-J. Langen, J. Breitkreutz, D. Willbold, A. Willuweit
  Preclinical pharmacokinetic studies of the tritium labelled D-enantiomeric peptide D3 developed for the treatment of Alzheimer´s disease
  PLoS One 10(6): e0128553 (2015)
   
• M. Rohrschneider, S. Bhagwat, R. Krampe, V. Michler, J. Breitkreutz, G. Hochhaus
  Evaluation of the Transwell® system for characterization of dissolution behavior of inhalation drugs: Effects of membrane and surfactant
  Mol. Pharm. 12: 2618-24 (2015)
   
• J. Walsh, M.C. Math, J. Breitkreutz, T. Zerback, H. Wachtel
  Devices for oral and respiratory paediatric medicines: What do healthcare professionals think?
  Int. J. Pharm. 492: 304-315 (2015)
   
• M. Preis, L. Grother, P. Axe, J. Breitkreutz
  In-vitro and in-vivo evaluation of taste-masked cetirizine hydrochloride formulated in oral lyophilisates
  Int. J. Pharm. 491: 8-16 (2015)
   
• M. Slavkova, J. Breitkreutz
  Orodispersible drug formulations for children and elderly
  Eur. J. Pharm. Sci. 75: 2-9 (2015)
   
• M. Guhmann, M. Preis, F. Gerber. N. Pöllinger, J. Breitkreutz, W. Weitschies
  Design, development and in vitro evaluation of diclofenac taste-masked orodispersible tablet formulations
  Drug Dev. Ind. Pharm. 41: 540-551 (2015)
   
• J.C. Visser, W.M.C. Dohmen, W.L.J. Hinrichs, J. Breitkreutz, H.W. Frijlink, H.J. Woerdenbag
  Quality by design approach for optimizing the formulation and physical properties of extemporaneously prepared orodispersible films?
  Int. J. Pharm. 485: 70-76 (2015)
   
• G. Petrovick, M. Pein, M. Thommes, J. Breitkreutz
  Spheronization of solid small lipid extrudates: an innovative approach in process control
  Eur. J. Pharm. Biopharm. 92: 15-21 (2015)
   
• B. Coulibaly, M. Pritsch, M. Bountogo, P.E. Meissner, E. Nebié, C. Klose, M. Kieser, N. Berens-Riha, A. Wieser, S.B. Sirima, J. Breitkreutz, R.H. Schirmer, A. Sié, F.P. Mockenhaupt, C. Drakeley, T. Bousema, O. Müller
  Efficacy and safety of triple combination therapy with artesunate-amodiaquine- methylene blue for falciparum malaria in children: a randomized controlled trial in Burkina Faso
  J. Infect. Dis. 211: 689-697 (2015)
   
• E M. Laukamp, A.K. Vynckier, J. Voorspels, M. Thommes, J. Breitkreutz
  Development of sustained and dual drug release co-extrusion formulations for individual dosing
  Eur. J. Pharm. Biopharm. 89: 357-364 (2015)
   
• C.M. Wagner, M. Pein, J. Breitkreutz
  Roll compaction of granulated mannitol grades and the unprocessed crystalline delta-polymorph
  Powder Technol. 270: 470-475 (2015)
   
• J.C. Visser, H.J. Woerdenbag, S. Crediet, E. Gerrits, M.A. Lesschen, W.L.J. Hinrichs, J. Breitkreutz, H.W. Frijlink
  Orodispersible films in individualized pharmacotherapy: the development of a formulation for pharmacy preparations
  Int. J. Pharm. 478: 155-163 (2015)
   

2014

• C. Eckert, M. Pein, J. Breitkreutz
  Lean production of taste masked lipidic sodium benzoate formulations
  Eur. J. Pharm. Biopharm. 88: 455-461 (2014)
   
• E M. Laukamp, M. Thommes, J. Breitkreutz
  Hot-Melt Extruded Drug-Loaded Rods: Evaluation of the Mechanical Properties for Individual Dosing via the Solid Dosage Pen
  Int. J. Pharm. 275: 344-350 (2014)
   
• M. Preis, D. Gronkowsky, D. Grytzan, J. Breitkreutz
  Comparative study on novel test systems to determine disintegration time of orodispersible films
  J. Pharm. Pharmacol. 66: 1102-1111 (2014)
   
• M. Preis, O. Häusler, J. Breitkreutz
  Electronic tongues in preformulation studies - Application of electronic tongues in preformulations studies to evaluate taste-masking capacities of maltodextrins
  Pharm. Ind. 76: 957-962 (2014)
   
• J. Walsh, A. Cram, C. Tuleu, G. Winzenburg, R. Turner, K. Woertz, J. Breitkreutz
  Playing hide and seek with poorly tasting paediatric medicines: do not forget the excipients
  Adv. Drug Deliv. Rev. 73: 14-33 (2014)
   
• M. Preis, C. Woertz, K. Schneider. J. Kukawka, J. Breitkreutz
  Bilayer oromucosal film preparations for local administration of lidocaine hydrochloride
  Eur. J. Pharm. Biopharm. 86: 552-561 (2014)
   
• S. Lindert, A. Below, J. Breitkreutz
  Performance of dry powder inhalers with single dosed capsules in preschool children and adults using improved upper airway models
  Pharmaceutics 6: 36-51 (2014)
   
• M. Preis, C. Eckert, O. Häusler, J. Breitkreutz
  A comparative study on solubilizing and taste-masking capacities of hydroxypropyl-ß-cyclodextrin and maltodextrins with high amylose content
  Sensors & Actuators B 193: 442-450 (2014)
   
• M. Preis, K. Knop, J. Breitkreutz
  Mechanical strength test for orodispersible and buccal films
  Int. J. Pharm. 461: 22-29 (2014)
   

 

---

 

2013

• S. Just, F. Sievert, M. Thommes, J. Breitkreutz
  Improved group contribution parameter set for the application of solubility parameters to melt extrusion
  Eur. J. Pharm. Biopharm. 85: 1191-1199 (2013)
   
• N. Genina, E.M. Janßen, A. Breitenbach, J. Breitkreutz, N. Sandler
  Evaluation of different substrates for inkjet-printing of rasagiline mesylate substrates
  Eur. J. Pharm. Biopharm. 85: 1075-1083 (2013)
   
• C. Woertz, M. Preis, J. Breitkreutz, P. Kleinebudde
  Assessment of test methods evaluating mucoadhesive polymers and dosage forms: an overview
  Eur. J. Pharm. Biopharm. 85: 843-853 (2013)
   
• V. Klingmann, N. Spomer, C. Lerch, I. Stoltenberg, C. Frömke, H.M. Bosse, J. Breitkreutz, T. Meissner
  Favourable acceptance of mini-tablets compared with syrup: a randomised controlled trial in infants and preschool children
  J. Pediatr. 163:1728-1732 (2013)
   
• B. Kollar, J. Breitkreutz, W. Wiedey, K. Bartscher, C. Döscher
  Innovative Mikrowellenresonanz-Sensoren für die Messung in Wirbelschichtgeräten
  TechnoPharm 3: 317-321 (2013)
   
• A. Zajicek, M.J. Fossler, J.S. Barrett, J.H. Worthington, R. Ternik, G. Charkoftaki, S. Lum, J. Breitkreutz, M. Baltezor, P. Macheras, M. Khan, S. Agharkar, D.D. MacLaren
  A report from the Pediatric Formulations Task Force: Perspectives on the state of child-friendly oral dosage forms
  AAPS J. 15: 1072-1081 (2013)
   
• M. Haupt, M. Thommes, A. Heidenreich, J. Breitkreutz
  Lipid-based intravesical drug delivery systems with controlled release of trospium chloride for the urinary bladder
  J. Control. Rel. 170: 161-166 (2013)
   
• M. Preis, C. Wörtz, P. Kleinebudde, J. Breitkreutz
  Characterization of oromucosal film preparations
  Exp. Opin. Drug Deliv. 10: 1303-1317 (2013)
   
• C.M. Wagner, M. Pein, J. Breitkreutz
  Roll compaction of mannitol: Compactability study of crystalline and spray-dried grades
  Int. J. Pharm. 453: 416-422 (2013)
   
• M. Pein, C. Eckert, M. Preis, J. Breitkreutz
  New protocol for Astree electronic tongue enabling full performance qualification according to ICH Q2 using caffeine citrate as model substance
  J. Pharm. Biomed. Anal. 83: 157-163 (2013)
   
• M. Guhmann, M. Thommes, F. Gerber, N. Pöllinger, S. Klein, J. Breitkreutz, W. Weitschies
  Design of biorelevant test setups for the prediction of diclofenac in vivo features after oral administration
  Pharm. Res. 30: 1483-1501 (2013)
   
• C. Eckert, M. Pein, J. Reimann, J. Breitkreutz
  Taste evaluation of multicomponent mixtures using a human taste panel, electronic taste sensing systems and HPLC
  Sensors and Actuators B 182: 294-299 (2013)
   
• A. Below, D. Bickmann, J. Breitkreutz
  Assessing the performance of two dry powder inhalers in preschool children using an idealized upper airway model
  Int. J. Pharm. 444: 169-174 (2013)
   
• E.M. Janßen, R. Schliephacke, A. Breitenbach, J. Breitkreutz
  Drug-printing by Flexography – a new manufacturing process for orodispersible films
  Int. J. Pharm. 441: 818-825 (2013)
   

---

 

 

2012

• N. Guffon, Y. Kibleur, W. Coppalu, C. Tissen, J. Breitkreutz
  Studies of a new formulation of sodium phenylbutyrate
  Arch. Dis. Child. 97: 1081-1085 (2012)
   
• K. Wening, E.J. Laukamp, M. Thommes, J. Breitkreutz
  Individual oral therapy with immediate release and  effervescent formulations delivered by the Solid Dosage Pen
  J. Pers. Med. 2: 217-231 (2012)
   
• M. Preis, M. Pein, J. Breitkreutz
  Development of a taste-masked orodispersible film containing dimenhydrinate
  Pharmaceutics 4: 551-562 (2012)
   
• M. Guhmann, M. Preis, F. Gerber, N. Pöllinger, J. Breitkreutz, W. Weitschies
  Development of oral taste masked diclofenac formulations using a taste sensing system
  Int. J. Pharm. 438: 81-90 (2012)
   
• C. Kindermann, K. Matthée, F. Sievert, J. Breitkreutz
  Electrolyte-stimulated biphasic dissolution profile and stability enhancement for tablets containing drug-polyelectrolyte complexes
  Pharm. Res. 29: 2710-2721 (2012)
   
• T. Ernest, J. Craig, A. Nunn, S. Salunke, C. Tuleu, J. Breitkreutz, R. Alex, J. Hempenstall
  Preparation of medicines for children – a hierachy of classification
  Int. J. Pharm. 435: 124-130 (2012)
   
• S. Stegemann, M. Gogol, J. Breitkreutz
  Swallowing dysfunction and dysphagia is an unrecognized challenge for oral drug therapy
  Int. J. Pharm. 430: 197-206 (2012)
   
• J. Vaassen, K. Bartscher, J. Breitkreutz
  Taste masked lipid pellets with enhanced release of hydrophobic active ingredient
  Int. J. Pharm. 429: 99-103 (2012)
   
• N. Spomer, V. Klingmann, I. Stoltenberg, C. Lerch, T. Meissner, J. Breitkreutz
  Acceptance of uncoated mini-tablets in young children – Results from a prospective exploratory cross-over study
  Arch. Dis. Child. 97: 283-286 (2012)

 

---

 2011

• K. Woertz, C. Tissen, P. Kleinebudde, J. Breitkreutz
  Development of a taste masked generic ibuprofen suspension - Top down approach guided by electronic tongue measurements
  J. Pharm. Sci. 100: 4460-4470 (2011)
   
• K. Woertz, C. Tissen, P. Kleinebudde, J. Breitkreutz
  Taste sensing systems (electronic tongues) for pharmaceutical applications
  Int. J. Pharm. 417: 256-271 (2011)
   
• C. Tissen, K. Woertz, J. Breitkreutz, P. Kleinebudde
  Development of mini-tablets with 1 mm and 2 mm diameter
  Int. J. Pharm. 416: 164-170 (2011)
   
• I. Stoltenberg, J. Breitkreutz
  Orally disintegrating mini-tablets (ODMTs) - A novel solid dosage form for paediatric use
  Eur. J. Pharm. Biopharm. 78: 462-469 (2011)
   
• J. Walsh, D. Bickmann, J. Breitkreutz, M. Chariot-Goulet
  Delivery devices for the administration of paediatric formulations: Overview of current practice, challenges and recent developments
  Int. J. Pharm. 415: 221-231 (2011)
   
• C. Eckert, C. Lutz, J. Breitkreutz, K. Woertz
  Quality control of oral herbal products by an electronic tongue - a case study on sage lozenges
  Sensors and Actuators B 156: 204-212 (2011)
   
• J. Breitkreutz, J. Boos
  Drug delivery and formulations
  in: H.W. Seyberth, A. Rane, M. Schwab (eds.): Handbook of Experimental Pharmacology, Vol. 205: Paediatric Clinical Pharmacology, S. 91-107, Springer-Verlag, Berlin Heidelberg (2011)
   
• K. Woertz, C. Tissen, P. Kleinebudde, J. Breitkreutz
  A comparative study on two electronic tongues for pharmaceutical formulation development
  J. Pharm. Biomed. Anal. 55: 272-281 (2011)
   
• E.M. Hoffmann, A. Breitenbach, J. Breitkreutz
  Advances in orodispersible films for drug delivery
  Exp. Opin. Drug Deliv. 8: 299-316 (2011)
   
• K. Wening, J. Breitkreutz
  Oral drug delivery in personalized medicine: Unmet needs and novel approaches
  Int. J. Pharm. 404: 1-9 (2011)

2010

• K. Woertz, C. Tissen, P. Kleinebudde, J. Breitkreutz
  "Qualification of an electronic tongue according to ICH guideline Q2"
  J. Pharm. Biomed. Anal. 51: 497-506 (2010)
   
• K. Woertz, C. Tissen, P. Kleinebudde, J. Breitkreutz
  "Rational development of taste masked oral liquids guided by an electronic tongue"
  Int. J. Pharm. 400: 114-123 (2010)
   
• S. Stegemann, F. Ecker, M. Maio, P. Kraahs, J. Breitkreutz, A. Zimmer, D. Bar-Shalom, P. Hettrich
  "Geriatric drug therapy: neglecting the inevitable majority"
  Ageing Res. Rev. 9: 384-398 (2010)
   
• M. Hermes, L. Barnscheid, V. Garsuch, P. Schoettler, J. Breitkreutz
  "Arzneimittelversorgung von Kindern – Ergebnisse einer Studie zur praktischen Auswirkung der EU-Verordnung 1901/2006 „Better Medicines for Children“ seit dem Inkrafttreten im Januar 2007"
  Pharm. Ind. 72: 1334-1344 (2010)
   
• I. Stoltenberg, G. Winzenburg, J. Breitkreutz
  "Solid oral dosage forms for children – formulations, excipients and acceptance issues"
  J. Appl. Ther. Res. 7: 141-146 (2010)
   
• K. Wening, J. Breitkreutz
  "Novel delivery device for monolithical solid oral dosage forms for personalized medicine"
  Int. J. Pharm. 395: 174-181 (2010)
   
• V. Garsuch, J. Breitkreutz
  "Comparative investigations on different polymers for the manufacturing of fast-dissolving oral films"
  J. Pharm. Pharmacol. 62: 539-545 (2010)
   
• K. Woertz, C. Tissen, P. Kleinebudde, J. Breitkreutz
  "Performance qualification of an electronic tongue according to ICH guideline Q2"
  J. Pharm. Biomed. Anal. 51: 497-506 (2010)
   
• S. Ramusovic, S. Läer, J. Breitkreutz
  "Bosentan in der Pädiatrie"
  Pharm. Unserer Zeit 39: 454-458 (2010)
   
• I. Stoltenberg, G. Winzenburg, J. Breitkreutz
  "Solid oral dosage forms for children – formulations, excipients and acceptance issues"
  Ind. Pharm. 27: 15-18 (2010)
   
• J. Breitkreutz, W. Friess
  "Kindgerechte Arznieimittel mit gentechnisch hergestellten Wirkstoffen"
  Annual Biotech-Report VfA, 46 (2010)
   
• I. Stoltenberg, J. Breitkreutz
  "Ludiflash®- preparation and characterization of orally disintegrating mini-tablets for pediatric use"
  ExAct 24: 7-10 (2010)
   
• J. Breitkreutz, W. Frieß
  "Kindgerechte Arzneimittel mit gentechnisch hergestellten Wirkstoffen"
  In: D. Michl, A. Heinemann (eds.): Medizinische Biotechnologie in Deutschland 2010 BCG GmbH, München (2010)
   
• J. Breitkreutz
  "Schnell zerfallende orale Arzneiformen"
  in K. Mäder, U. Weidenauer (eds.): Innovative Arzneiformen, Wissenschaftliche Verlagsgesellschaft, Stuttgart, ISBN-13: 978-3-8047-2455-6 (2010)
   
• P. Rohdewald, G. Rücker, K.W. Glombitza, bearbeitet von J. Breitkreutz, K.W. Glombitza, G. Rücker, M.A. Hubert
  "Apothekengerechte Prüfvorschriften"
  Deutscher Apotheker Verlag, Stuttgart 13. Erg.-Lieferung (2010): ISBN 978-3-7692-5192-0

 2009

• C. Buschmüller, W. Wiedey, C. Döscher, M. Plitzko, J. Breitkreutz
  "In-line monitoring of granule moisture and temperature throughout the entire fluidized-bed granulation process using microwave resonance technology"
  Part I: Pharm. Ind. 71: 1403-1408 (2009)
  Part II: Pharm. Ind. 71: 1614-1620 (2009)
   
• V. Garsuch, J. Breitkreutz
  "Novel analytical methods for the characterization of oral wafers"
  Eur. J. Pharm. Biopharm. 73:195-201 (2009)
   
• J. Krause, M. Thommes, J. Breitkreutz
  "Immediate release pellets with lipid binders obtained by solvent-free cold extrusion"
  Eur. J. Pharm. Biopharm. 71: 138-144 (2009)
   
• A. Cram, J. Breitkreutz, S. Desset-Brèthes, T. Nunn, C. Tuleu
  "Challenges of developing palatable oral paediatric formulations"
  Int. J. Pharm. 365: 1-3 (2009)
   
• J. Breitkreutz
  "Excipients for paediatric use"
  Bulletin Technique Gattefossé 102: 71-75 (2009)
   
• J. Breitkreutz
  "Pharmazeutisch-technologische und biopharmazeutische Aspekte der Thrombozytenaggregationshemmer"
  Pharm. Unserer Zeit 38: 330-337 (2009)
   
• J. Breitkreutz
  "Arzneiformen für Kinder"
  Pharm. Unserer Zeit 38: 30-37 (2009)
   
• P. Rohdewald, G. Rücker, K.W. Glombitza, bearbeitet von J. Breitkreutz, K.W. Glombitza, G. Rücker, M.A. Hubert
  "Apothekengerechte Prüfvorschriften"
  Deutscher Apotheker Verlag, Stuttgart 12. Erg.-Lieferung (2009): ISBN 978-3-7692-4192-1
   
• J. Breitkreutz
  "Schnell zerfallende orale Arzneiformen"
  in C. Mäder, U. Weidenauer (eds.): Innovative Arzneiformen, 3. Aufl., Wissenschaftliche Verlagsgesellschaft, Stuttgart, ISBN-13: 978-3-8047-2455-6 (2009)

 2008

• J. Breitkreutz
  "European perspectives on pediatric formulations"
  Clin. Ther. 30: 2146-2154 (2008)

• C. Buschmüller, W. Wiedey, C. Döscher, J. Dressler, J. Breitkreutz
  "In-line monitoring of granule moisture in fluidized bed dryers using Microwave Resonance Technology"
  Eur. J. Pharm. Biopharm. 69: 380-387 (2008)

• J. Krause, J. Breitkreutz
  "Improving drug delivery in pediatric medicine"
  Pharm. Med. 22: 41-50 (2008)

• J. Breitkreutz
  "Die elektronische Zunge. Geschmacksvorhersage mittels Chemosensorenarray-System"
  GIT Labor-Fachzeitschrift 3/2008, 257

• J. Breitkreutz
  "Geschmacksmaskierung – Bittere Arzneistoffe gut kaschiert"
  Pharm. Ztg., 153: 376-383 (2008)

• J. Breitkreutz
  "Geschmacksmaskierung und andere galenische Tricks zur Verbesserung der Compliance"
  Pharm. Ztg. 153 Suppl. 1: 6-9 (2008)

• J. Breitkreutz, R. Eifler-Bollen, A. Kiefer
  "Fit für die Rezeptur – Ein Trainingsbuch für das Apothekenteam"
  Govi-Verlag, Eschborn; 1. Auflage (2008): ISBN-13:978-3-7741-1074-8 

 2007

• J. Breitkreutz, J. Boos
  "Paediatric and geriatric drug delivery"
  Exp. Opin. Drug Deliv. 4: 37-45 (2007)

• J. Breitkreutz, T. G. Gan, B. Schneider, P. Kalisch
  "Enteric-coated solid dosage forms containing sodium bicarbonate as a drug substance: an exception from the rule? "
  J. Pharm. Pharmacol. 59: 59-65 (2007)

• J. Breitkreutz, C. Tuleu, D. Solomonidou
  "Paediatric formulations"
  In: K. Rose, J. N. van den Anker (Hrsg.): Guide to paediatric clinical research, 65-77, S. Karger AG, CH-Basel, (2007) ISBN-13: 978-3-8055-8201-8 

• K. Grießmann, J. Breitkreutz, M. Schubert-Zsilavecz, M. Abdel Tawab
  "Dosing accuracy of measuring devices provided with antibiotic oral suspensions"
  Paed. Perinat. Drug Ther. 8: 61-70 (2007)

• J. Breitkreutz, J. Buckham, M. Fischer, R. Pöstges, J. Boos
  "Comparative in vitro-studies on different 6-mercaptopurine formulations for the use in children"
  Paed. Perinat. Drug Ther. 8: 31-39 (2007)

• J. Breitkreutz, U. Holzgrabe, P. Kleinebudde, K. Michel, A. Ritter, F. Stieneker"
  Wann Tabletten geteilt werden dürfen"
  Dtsch. Apoth. Ztg. 147: 2854-2855 (2007)

 2006

• J. Breitkreutz
  "Arzneizubereitungen für Kinder"
  Pharm. Ztg. 151 Suppl.: 21-24 (2006)

• L. Barnscheid, J. Kakkanattuparambil, H. Yildirim, J. Breitkreutz
  "Hydrochlorothiazid – Kapsel-Herstellung auf dem Prüfstand"
  Pharm. Ztg. 151: 4812-4816 (2006)

• J. Breitkreutz
  "Rezepturarzneimittel im Krankenhaus – Erste systematische Auswertung von Verordnungsdaten"
  Management & Krankenhaus (11): 29 (2006)

• S. Läer, K. G. Schmidt, J. Breitkreutz
  "Europäische Union zeigt Herz für Kinder"
  Cardio News 9 (7-8): 33 (2006)

• K. Grießmann, J. Breitkreutz, P. Schoettler, M. Schubert-Zsilavecz, M. Tawab
  "Dosiergenauigkeit und sichere Anwendung von Amoxicillintrockensäften"
  päd Praktische Pädiatrie 8: 266-271 (2006)

• M. Bonati, J. Breitkreutz, I. Choonara, K. Hoppu, E. Jacqz-Aigrain, J.-P. Langhendries, G. Pons, A. Rane, H. Seyberth, J. van den Anker
  "Paediatric clinical pharmacology in Europe"
  Paed. Perinat. Drug Ther. 7: 134-137 (2006)

• P. Rohdewald, G. Rücker, P. Glombitza, unter Mitarbeit von J. Breitkreutz
  "Apothekengerechte Prüfvorschriften"
  11. Erg.-Lieferung Deutscher Apotheker Verlag, Stuttgart (2006; ISBN 3-7692-4191-6

• J. Breitkreutz
  "Colestyramin Ph. Eur. 5.0"
  Kommentar zum Europäischen Arzneibuch, Wiss. Verlagsges. Stuttgart (2006);
  ISBN 3-8047-2268-7 (Akt.-lieferung), ISBN 3-8047-2269-5 (Grundwerk)

• J. Breitkreutz
  "Kindgerechte Arzneizubereitungen"
  In: A. Labisch (Hrsg.): Jahrbuch der Heinrich-Heine-Universität Düsseldorf 2005/2006, S. 161-172
  Heinrich-Heine-Universität, Düsseldorf (2006); ISBN 3-9808514-4-3

• J. Breitkreutz
  "Novel approaches to the route of administration"
  In E. Jacqz-Aigrain, I. Choonara (Hrsg.): Paediatric Clinical Pharmacology. 235-243,
  1. Aufl., FontisMedia S.A., CH-Lausanne and  Taylor & Francis, US-New York (2006), ISBN 0-8247-2189-6

2005

• K. Grießmann, J. Breitkreutz, P. Schoettler, M. Schubert-Zsilavecz, M. Abdel Tawab
  "Amoxicillintrockensäfte - Dosierungsgenauigkeit und sichere Handhabung"
  Monatsschr. Kinderheilkd. 153: 735-740 (2005) 

• J. Breitkreutz
  "Kindgerechte Arzneiformen - Neue Produkte und Entwicklungsprojekte"
  Monatsschr. Kinderheilkd. 153: 726-734 (2005)

• J. Breitkreutz
  "Was zeichnet kindgerechte Arzneimittel aus?"
  Der Allgemeinarzt 42-44 (2005)

• J. Breitkreutz
  "Pharmazeutisch-technologische und biopharmazeutische Aspekte der Arzneizubereitungen mit Protonenpumpenhemmern"
  Pharm. Unserer Zeit 34: 216-223 (2005) 

 2004

• J. Breitkreutz
  "Kindgerechte Arzneizubereitungen zur peroralen Anwendung"
  Habilitationsschrift, Universität Münster (2004)

• R.S. Müller, J. Breitkreutz, R. Gröning
  "Interactions between aqueous Hypericum perforatum extracts and drugs: in vitro studies"
  Phytother. Res. 18: 1019-1023 (2004)

• H. Neye, J. Breitkreutz
  "Spezielle Aspekte der Arzneimitteltherapie in Kindheit und Alter"
  Med. Monatsschr. Pharm. 27: 161-167 (2004)

 2003

• J. Breitkreutz, F. El-Saleh, C. Kiera, P. Kleinebudde, W. Wiedey
  "Pediatric drug formulations of sodium benzoate: II. Coated granules with a lipophilic binder"
  Eur. J. Pharm. Biopharm. 56: 255-260 (2003)

• C. Reinke, J. Breitkreutz, H. Leuenberger
  "Aluminium in drugs - risks outweigh benefits ?"
  Drug Safety (2003)

• J. Breitkreutz, M. Bornhöft, F. Wöll, P. Kleinebudde
  "Pediatric drug formulations of sodium benzoate: I. Coated granules with a hydrophilic binder"
  Eur. J. Pharm. Biopharm. 56: 247-253 (2003)

• R. Gröning, J. Breitkreutz, R.S. Müller
  "Physico-chemical interactions between extracts of Hypericum perforatum L. and drugs"
  Eur. J. Pharm. Biopharm. 56: 231-236 (2003)

• B. Chankvetadze, K. Lomsadze, N. Burjanadze, J. Breitkreutz, G. Pintore, M. Chessa, K. Bergander, G. Blaschke
  "Comparative enantioseparations with native b-cyclodextrin, randomly acetylated b-cyclodextrin and heptakis-(2,3-di-O-acetyl)-b-cyclodextrin in capillary electrophoresis"
  Electrophoresis 24: 1083-1091 (2003)

• J. Breitkreutz, T. Wessel, J. Boos
  "13. Dosage forms for oral drug administration"
  In I. Choonara, T. Nunn, G. Kearns (Hrsg.): Introduction to paediatric and perinatal drug therapy, 189-205
  1.Aufl., Nottingham University Press (2003), ISBN 1-897676-37-9

 2002

• B. Chankvetadze, N. Burjanadze, J. Breitkreutz, K. Bergander, D. Bergenthal, O. Kataeva, R. Fröhlich, H. Luftmann, G. Blaschke
  "Mechanistic study on the opposite migration order of the enantiomers of ketamine with alpha- and beta-cyclodextrins in capillary electrophoresis"
  J. Sep. Sci. 25: 1155-1166 (2002)

• J. Breitkreutz, J. Boos, P. Kleinebudde
  "Kindgerechte Darreichungsformen - Arzneimitteltherapie für alle"
  Pharm. Ztg. 147: 16-24 (2002)

• R. Gröning, J. Breitkreutz, V. Baroth, R.S. Müller
  "Nanoparticles in plant extracts - influence of drugs on the formation of nanoparticles and precipitates in black tea infusions"
  Eur. J. Pharm. Sci. 15: 149-155 (2002)

• J. Breitkreutz
  "Kindgerechte Darreichungsformen"
  In Health Care NRW e.V. (Ed.): Arzneimittel für Kinder und Jugendliche - aktueller Stand und Entwicklungsmöglichkeiten 12-13 (2002)

 2001

• R. Gröning, J. Breitkreutz, V. Baroth, R.S. Müller
  "Nanoparticles in plant extracts - factors which influence the formation of nanoparticles in black tea infusions"
  Pharmazie 56: 790-792 (2001)

• W. Weitschies, R. Grützmann, V. Hartmann, J. Breitkreutz
  "Determination of the disintegration behaviour of magnetically marked tablets"
  Eur. J. Pharm. Biopharm. 52: 221-226 (2001)

• B. Chankvetadze, I. Kartozia, J. Breitkreutz, Y. Okamoto, G. Blaschke
  "Effect of organic solvent, electrolyte salt and a loading of cellulose tris(3,5-dichlorophenylcarbamate) on silica gel on enantioseparation characteristics in capillary electrochromatography"
  Electrophoresis 22: 3327-3334 (2001)

• B. Chankvetadze, K. Lomsadze, D. Bergenthal, J. Breitkreutz, K. Bergander, G. Blaschke
  "Mechanistic study on the opposite migration order of clenbuterol enantiomers in capillary electrophoresis with beta-CD and single isomer heptakis-(2,3-diacetyl-6-sulfo)-beta-cyclodextrin"
  Electrophoresis 22: 3178-3184 (2001)

• T. Wessel, J. Breitkreutz, E. Ahlke, G. Hempel, J. Boos
  "Probleme in der Dauertherapie mit Mercaptopurin-Tabletten"
  Krankenhauspharmazie 22: 325-329 (2001)

• W. Weitschies, M. Karaus, D. Cordini, L. Trahms, J. Breitkreutz, W. Semmler
  "Magnetic marker monitoring of disintegrating capsules"
  Eur. J. Pharm. Sci. 13: 411-416 (2001)

• B. Chankvetadze, I. Kartozia, J. Breitkreutz, M. Girod, M. Knobloch, Y. Okamoto, G. Blaschke
  "Comparative capillary chromatographic and capillary electrochromatographic enantioseparations using cellulose tris(3,5-dichlorophenylcarbamate) as a chiral stationary phase"
  J. Sep. Sci. 24: 251-257 (2001)

• J. Breitkreutz, G. Heun
  "Grundlagen der Physikalischen Chemie für Pharmazeuten"
  1st edition, IPT-Verlag Münster (2001), ISBN 3-9803753-5-8

 2000

• G. Yener, Y. Topaloglu, J. Breitkreutz
  "Enhancement of dissolution of tiaprofenic acid via inclusion with skimmed milk"
  S.T.P. Pharma Sci. 10: 401-404 (2000)

• J. Breitkreutz
  "Leakage of Enteric (Eudragit L)-Coated Dosage Forms in Simulated Gastric Juice in the Presence of Poly(ethylene glycol)"
  J. Control. Release 67: 79-88 (2000)

• B. Chankvetadze, G. Pintore, N. Burjanadze, D. Bergenthal, K. Bergander, J. Breitkreutz, C. Mühlenbrock, G. Blaschke
  "Mechanistic study of opposite migration order of dimethindene enantiomers in capillary electrophoresis in the presence of native beta-CD and  heptakis-(2,3,6-tri-O-methyl)-beta-CD"
  J. Chromatogr. A 875: 455-469 (2000)

• B. Chankvetadze, N. Burjanadze, G. Pintore, D. Bergenthal, K. Bergander, C. Mühlenbrock, J. Breitkreutz, G. Blaschke
  "Separation of brompheniramine enantiomers in capillary electrophoresis and study of chiral recognition mechanisms of cyclodextrins using NMR-spectroscopy, UV spectrometry, ESI-MS and x-ray crystallography"
  J. Chromatogr. A 875: 471-484 (2000)

 vor 2000

• J. Breitkreutz, T. Wessel, J. Boos
  "Dosage Forms for Peroral Drug Administration to Children"
  Paediatr. Perinatal Drug Therap. 3: 25-33 (1999)

• H. Bensmann, B. Borchard, J. Breitkreutz, C. Cloer, C. Drengenberg, G. Heun, E. Kuhlmann, U. Kuhland, R. Möwes, S. Remmerbach, C. Walz
  "Zukunftsorientierte Arzneimittelentwicklung - Beispiele für biomedizinisch orientierte Forschung in der Pharmazeutischen Technologie"
  Forschungsjournal der WWU Münster 7: 16-20 (1998)

• J. Breitkreutz
  "Prediction of Intestinal Drug Absorption Properties by Three-Dimensional Solubility Parameters"
  Pharm. Res. 15: 1370-1375 (1998)

• Y. Topaloglu, G. Yener, J. Breitkreutz
  "Preparation of sulindac with skimmed milk via freeze-drying"
  Pharmazie 53: 327-329 (1998)

• G. Heun, J. Breitkreutz
  "Experimental and molecular modelling studies on the incompatibility of phenolic preservatives with polyethylene glycols"
  Pharm. Pharmacol. Lett. 6: 60-63 (1996)

• J. Breitkreutz
  "Molecular Modeling-Studien und experimentelle Untersuchungen zur molekularen Struktur von Polyethylenglykolen und zu deren Wechselwirkungen mit Wasser und Phenol"
  Dissertation, Universität Münster (1996), erschienen im Shaker Verlag Aachen, ISBN 3-8265-1599-4R.

• Gröning, V. Baroth, J. Breitkreutz
  "Nanoparticles in plant extracts - investigations into the colloidal structure of aqueous infusions of black tea"
  Pharm. Pharmacol. Lett. 2: 77-79 (1995)

• G. Heun, J. Breitkreutz
  "Structures and molecular attributes of polyethylene glycols"
  Pharmazie 49: 562-566 (1994)

• J. Breitkreutz
  "Entwicklung eines Computerprogramms zur rechnerunterstützten Herstellung von Augentropfen"
  Diplomarbeit, E. M. Arndt-Universität Greifswald (1992)